Record Date for Jaguar Health's Special One-time Stock Dividend

Jaguar Health, Inc. announced March 2, 2026, as the Record Date for its special one-time stock dividend. This dividend, consisting of Series O Convertible Preferred Stock, aims to protect shareholders from dilution as the company navigates debt restructuring. Two days later, on March 4, 2026, eligible holders of Jaguar Common Stock and certain warrants will receive this dividend automatically.

Lisa Conte, CEO, emphasized the strategic importance of this move. Jaguar's focus remains on developing crofelemer for rare gastrointestinal conditions, notably through a January 2026 agreement with Future Pak for Mytesi®. The Preferred Stock is non-tradable and not listed on any exchange. For more details, refer to Jaguar's filing with the U.S. SEC.